#72 Notable Clinical Interest
Emerging findings or policy developments worth monitoring closely.
Clinicians should be aware that cannabis use in older adults is associated with poor mental health outcomes, which requires screening and counseling as part of comprehensive geriatric care. Understanding this association helps providers address modifiable risk factors that could improve both mental health and overall quality of life in aging patients. This evidence supports integrating cannabis use assessment into standard mental health evaluations, particularly for older adults presenting with depression or anxiety.
A recent study examining cannabis use patterns in the United States has identified associations between increasing cannabis consumption and adverse mental health outcomes in the population studied. The research suggests that clinicians should remain vigilant about cannabis use as a potential contributing factor to depression, anxiety, and other psychiatric symptoms, particularly as usage rates continue to rise across demographic groups. This finding is especially relevant for geriatricians and other primary care providers who take a comprehensive approach to patient health, as cannabis use may interact with existing mental health conditions or medications commonly prescribed to older adults. The study underscores the importance of obtaining detailed substance use histories and screening for mental health changes in patients who report cannabis use, regardless of whether they use it recreationally or believe it to be therapeutic. Clinicians should counsel patients that while cannabis is increasingly available and normalized, emerging evidence links its use to mental health risks that warrant careful consideration before recommending or endorsing its use. Practitioners should routinely ask about cannabis use during mental health assessments and consider it as a potential modifiable risk factor when patients present with depression or anxiety.
“What we’re seeing in clinical practice is that cannabis use doesn’t exist in a vacuum—it intersects with underlying anxiety, depression, and isolation, and while some patients do benefit from carefully dosed cannabinoids, we cannot ignore that for others, particularly those with genetic vulnerability to psychiatric illness, cannabis is exacerbating rather than treating their mental health. The challenge for us as clinicians is moving past ideology in either direction and actually screening for psychiatric risk before recommending cannabis, just as we would with any other medication.”
💊 While observational studies linking cannabis use to poor mental health outcomes warrant clinical attention, providers should recognize that establishing causation remains challenging given the bidirectional relationship between substance use and psychiatric symptoms—individuals with preexisting mental health conditions may be more likely to self-medicate with cannabis rather than cannabis causing deterioration. The heterogeneity of cannabis products, dosing patterns, and individual vulnerabilities (age, genetics, concurrent medications) means that population-level associations may not predict individual patient outcomes, and the growing use among older adults in particular requires consideration of age-related pharmacokinetics and polypharmacy interactions. Clinicians should incorporate cannabis use into comprehensive psychiatric and substance use screening while remaining alert to potential mental health sequelae, but avoid reflexive condemnation in favor of shared decision-making conversations that acknowledge both emerging harms and patients’ actual or perceived therapeutic benefits. A practical approach involves documenting cannabis use patterns and frequency, monitoring
💬 Join the Conversation
Have a question about how this applies to your situation? Ask Dr. Caplan →
Want to discuss this topic with other patients and caregivers? Join the forum discussion →
Have thoughts on this? Share it:
- Study Links Rising Cannabis Use to Poor Mental Health – HealthDay
- Daily Digest: Last 19 Hours: Aging Brains, Adolescent Risk, and the Slow March of Policy Reform — March 04, 2026
- Daily Digest: Last 48 Hours: Adolescent Risk, Aging Brains, and the Long Road to Pharmaceutical-Grade Cannabis — March 04, 2026